Reuters logo
4 years ago
BRIEF-GW Pharmaceuticals says Epidiolex granted orphan drug designation by FDA
November 15, 2013 / 7:16 AM / 4 years ago

BRIEF-GW Pharmaceuticals says Epidiolex granted orphan drug designation by FDA

Nov 15 (Reuters) - GW Pharmaceuticals PLC : * Orphan drug designation granted for epidiolex in dravet syndrome by the FDA * U.S. pediatric epilepsy specialists to treat high need pediatric epilepsy

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below